AHA 2019: Type 2 Myocardial Infarction Results in Higher Risk Than Type 1
Patients who experience Type 2 myocardial infarction are at higher risk for additional cardiovascular events and death than patients who experience Type 1 myocardial infarction (MI), according to a new analysis from the DCRI. The analysis, which the DCRI’s Chiara Melloni, MD, presented as an oral abstract Saturday at the American Heart Association Scientific Sessions 2019 in Philadelphia, examined data from three completed DCRI-led trials to shed new light on the differences between patients who experience Type 1 MI and those who experience Type 2 MI.
DCRI Contributes to Important Results Presented at AHA 2019
The DCRI served as the statistical and data coordinating center for ISCHEMIA, a late-breaking clinical trial that indicated invasive heart procedures may not reduce the chance of experiencing a maj
DCRI to Partner With Amgen on Large-Scale Registry
By enrolling 8,500 high-risk patients with a recent atherosclerotic cardiovascular disease event, cvMOBIUS will be the first large-scale registry to evaluate real-world lipid management and the effectiveness of PCSK9 inhibitors.
Innovating Adjudication
As the DCRI’s Clinical Events Classification (CEC) group grows, its leaders are seeking innova
DCRI Researchers Weigh In On Wearables in Heart Failure Care
Researchers from the DCRI are optimistic about the opportunities that wearable devices present in caring for patients with heart failure; however, they also recognize that challenges must be overcome to successfully interpret and act upon patient data collected from wearables.
Tool to Assess Cardiovascular Risk May be Inaccurate in Older Adults
A DCRI-led study is the first to test the performance of the Pooled Cohort Risk Equations, a commonly used tool for assessing cardiovascular risk, in older adults.
DCRI Releases White Paper Providing Guidance on Pediatric Research
Through its work with the Global Pediatric Clinical Trials Research Network, the DCRI worked with sponsors to help navigate challenges associated with pediatric clinical research.
DCRI Pediatrician Contributes to Guidance on Pediatric Weight-Loss Surgery
The DCRI’s Sarah Armstrong, MD, served as the lead author for a policy statement and a co-author on a technical report advocating for more widespread use of bariatric and metabolic surgeries for ch
DCRI to Lead Pragmatic Study to Assess Effectiveness of Statins in Older Adults
A $90 million award expected from the National Institute of Aging and the National Heart, Lung, & Blood Institute will fund the largest pragmatic trial with placebo-controlled drug assignm
DCRI Receives Grant to Develop Measures for Pain in Infants and Young Children
Investigators will develop a core set of endpoints and measures to be used in clinical trials and spur development of new pain medications for young children.